Skip to main content
Log in

A novel menin gene deletional mutation in a little series of Italian patients affected by apparently sporadic multiple endocrine neoplasia type 1 syndrome

  • Rapid Communication
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Aim: To perform a genetic screening for the multiple endocrine neoplasia type 1 (MEN1) gene mutations in patients affected by an apparently sporadic form of the disease, referred to an internal medicine unit of a large general hospital. Subjects and methods: In a group of 12 consecutive patients presenting clinical features of MEN type 1 syndrome, we performed a genetic screening for germline MEN1 gene mutations, including complete sequencing of the coding region (exons 2 to 10) and multiplex ligation-dependent probe amplification analysis for large deletion detection. Results: Among these patients affected by apparently sporadic MEN type 1 syndrome, a targeted clinical history could detect indirect support for a diagnosis of familial condition only in 2 cases. The genetic screening identified pathogenic germline MEN1 gene mutations in 3 patients (25%). A previously unknown 18 base-pair deletion within exon 3, c.564_581 delCAATGGGGAGCAGACAGC, resulting in loss of 6 amino acids (pAsp189_Ala194del), was found in heterozygosis in a woman affected by primary hyperparathyroidism and multifocal pancreatic neoplasia. Conclusions: Our results underscore the importance of performing genetic testing also in apparently sporadic MEN1 patients and extend the list of molecular variants leading to inactivation of the MEN1 gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 2008, 29: 22–32.

    Article  CAS  PubMed  Google Scholar 

  2. Cebrián A, Ruiz-Llorente S, Cascón A, et al. Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients. J Med Genet 2003, 40: e72.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Pannett AA, Thakker RV. Multiple endocrine neoplasia type 1. Endocr Rel Canc 1999, 6: 449–73.

    Article  CAS  Google Scholar 

  4. Kouvaraki MA, Lee JE, Shapiro SE, et al. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Arch Surg 2002, 137: 641–7.

    Article  PubMed  Google Scholar 

  5. Trump D, Farren B, Wooding C, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 1996, 89: 653–69.

    Article  CAS  PubMed  Google Scholar 

  6. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA. Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 1998, 129: 484–94.

    Article  CAS  PubMed  Google Scholar 

  7. Bassett JH, Forbes SA, Pannett AA, et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 1998, 62: 232–44.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA Jr, Norton JA. Lethality of multiple endocrine neoplasia type I. World JSurg 1998, 22: 581–6.

    Article  CAS  Google Scholar 

  9. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2. J Clin Endocrinol Metab 2001, 86: 5658–71.

    Article  CAS  PubMed  Google Scholar 

  10. Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 2008, 29: 22–32.

    Article  CAS  PubMed  Google Scholar 

  11. Chandrasekharappa SC, Teh BT. Functional studies of the MEN1 gene. J Intern Med 2003, 253: 603–15.

    Article  Google Scholar 

  12. Poisson A, Zablewska B, Gaudray P. Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1. Cancer Lett 2003, 189: 1–10.

    Article  CAS  PubMed  Google Scholar 

  13. Balogh K, Patócs A, Hunyady L, Rácz K. Menin dynamics and functional insight: take your partners. Mol Cell Endocrinol 2010, 326: 80–4.

    Article  CAS  PubMed  Google Scholar 

  14. Agarwal SK, Novotny EA, Crabtree JS, et al. Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter. Proc Natl Acad Sci 2003, 100: 10770–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Gracanin A, Dreijerink KM, van der Luijt RB, Lips CJ, Höppener JW. Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis. Cancer Res 2009, 69: 6371–4.

    Article  CAS  PubMed  Google Scholar 

  16. Guo SS, Sawicki M P. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type 1. Mol Endocrinol 2001, 15: 1653–64.

    Article  CAS  PubMed  Google Scholar 

  17. Bosman F, Carneiro F, Hruban R, et al. WHO Classifcation of tumors of the digestive system. Lyon: IARC Press, 2010.

    Google Scholar 

  18. Schmidt MC, Henke RT, Stangl AP, et al. Analysis of the MEN1 gene in sporadic piytuitary adenomas. J Pathol 1999, 188: 168–73.

    Article  CAS  PubMed  Google Scholar 

  19. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997, 276: 404–7.

    Article  CAS  PubMed  Google Scholar 

  20. Ferolla P, Falchetti A, Filosso P, et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab 2005, 90: 2603–9.

    Article  CAS  PubMed  Google Scholar 

  21. Falchetti A, Marini F, Luzi E et al. Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. Genet Med 2009, 11: 825–35.

    Article  CAS  PubMed  Google Scholar 

  22. Marinoni I, Pellegata NS. p27kip1: a new multiple endocrine neoplasia gene? Neuroendocrinology 2011, 93: 19–28.

    Article  CAS  PubMed  Google Scholar 

  23. Georgitsi M. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations. Best Pract Res Clin Endocrinol Metab 2010, 24: 425–37.

    Article  CAS  PubMed  Google Scholar 

  24. Georgitsi M, Raitila A, Karhu A, et al. Germline CDKN1 B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 2007, 92: 3321–5.

    Article  CAS  PubMed  Google Scholar 

  25. Stratakis CA, Tichomirowa MA, Boikos S, et al. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet 2010, 78: 457–63.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Klein RD, Salih S, Bessoni J, Bale AE. Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory. Genet Med 2005, 7: 131–8.

    Article  CAS  PubMed  Google Scholar 

  27. Wautot V, Vercherat C, Lespinasse J, et al. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Hum Mutat 2002, 20: 35–47.

    Article  CAS  PubMed  Google Scholar 

  28. The Universal Mutation Database. The MEN1 mutations database. http://www.umd.be/MEN1/

  29. Kassem M, Kruse TA, Wong FK, Larsson C, Teh BT. Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree. J Clin Endocrinol Metab 2000, 85: 165–7.

    CAS  PubMed  Google Scholar 

  30. Teh BT, Farnebo F, Twigg S, et al. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21–q32 in a subset of families. J Clin Endocrinol Metab 1998, 83: 2114–20.

    CAS  PubMed  Google Scholar 

  31. Fujimori M, Shirahama S, Sakurai A, et al. Novel V184E MEN1 germline mutation in a Japanese kindred with familial hyperparathyroidism. Am J Med Genet 1998, 80: 221–2.

    Article  CAS  PubMed  Google Scholar 

  32. Belar O, De la Hoz C, Pérez-Nanclares G, Castaño L, Gaztambide S; Spanish MEN1 Group. Novel mutations In MEN1, CDKN1b and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain. Clin Endocrinol 2011, Oct 25 [Epub ahead of print]; doi: 10.1111/j.1365-2265.2011.04269.x

  33. Hou R, Manwaring LP, Moley JF, Whelan A. A novel missense mutation in the MEN1 gene in a patient with multiple endocrine neoplasia type 1. Endocr Pract 2011, 17: e63–7.

    Article  PubMed  Google Scholar 

  34. Raef H, Zou M, Baitei EY, et al. A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype. Clin Endocrinol 2011, 75: 791–800.

    Article  CAS  Google Scholar 

  35. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003, 21: 2397–406.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Giacché MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giacché, M., Panarotto, A., Mori, L. et al. A novel menin gene deletional mutation in a little series of Italian patients affected by apparently sporadic multiple endocrine neoplasia type 1 syndrome. J Endocrinol Invest 35, 124–128 (2012). https://doi.org/10.1007/BF03345419

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345419

Key-words

Navigation